Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diclofenac | HCID 3033 | — |
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | HCID 71650669 | HCID 71650669 | — |
| Catalyst | 4-(Dimethylamino)pyridine | HCID 14284 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 178458017 | HCID 178458017 | 157,164.297% |
Reaction Steps
In 3 ml of dichloromethane, 338.4 mg (1.94 mmol) of tert-butyl N-(2-aminopropyl)carbamic acid (manufactured by Tokyo Kasei Kogyo) and 694.4 mg (2.34 mmol) of diclofenac were dissolved, and under ice-cooling, 59.0 mg (0.483 mmol) of DMAP and 505.3 mg (2.64 mmol) of WSCI.HCl were added thereto, followed by stirring for 70 minutes and then stirred at room temperature for 90 minutes. Ethyl acetate was added thereto, followed by separation by washing with 5% aqueous citric acid solution, 5% aqueous sodium hydrogen carbonate solution and saturated brine consecutively. After dehydration with sodium sulfate, ethyl acetate was evaporated under reduced pressure. The resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate=2:1) to give 835.5 g (95%) of the titled compound. The structure was identified by 1H-NMR.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07879817B2 |
|---|
| Source dataset | uspto-grants-2011_02 |
|---|
| ORD ID | ord-b8b0bbfc68c74bfb9213ac7e22e6ed50 |
|---|
| Source note | uspto-grants-2011_02 |
|---|